JUL 28, 2018 12:46 PM PDT

23andMe Announces Partnership with Drug Company GSK

WRITTEN BY: Carmen Leitch

The commercial gene sequencing company 23andMe and GlaxoSmithKline (GSK) have announced a partnership that is planned for the next four years. GSK will use the massive repository of genetic and personal data that 23andMe has gathered over the years to improve the development of medications, and potentially, cures for diseases. Many disorders lack effective therapies, and the partnership wants to address that.

“Partnering with 23andMe, an organization whose vision and capabilities are transforming the understanding of how genes influence health, will help to shift our research and development organization to be ‘driven by genetics’, and increase the impact GSK can have on patients,” said Dr. Hal Barron, Chief Scientific Officer and President R&D, GSK.  

“This collaboration will enable us to deliver on what many customers have been asking for — cures or treatments for diseases.  By leveraging the genetic and phenotypic information provided by consenting 23andMe customers and combining it with GSK’s incredible expertise and resources in drug discovery, we believe we can more quickly make treating and curing diseases a reality,” said Anne Wojcicki, CEO and Co-founder of 23andMe.

They aim to improve precision medicines that can be used on patients that carry specific sequences in a gene that has left them susceptible to an associated disease. They also want to find the best way to identify patients who could participate in drug trials. There won’t be any immediate reward for those participants, but the upside of course, is that effective therapeutics for serious illnesses might be engineered. A possible downside is that many people will contribute to potentially groundbreaking or profitable research that will be out of their reach.

Source: 23andMe

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 17, 2019
Space & Astronomy
DEC 17, 2019
What to Expect From Boeing's Starliner Spacecraft
NASA’s Commercial Crew Program sports two major contenders for sending astronauts to the International Space Station from American soil for the first...
DEC 29, 2019
Space & Astronomy
DEC 29, 2019
The Dangers of Space Debris Explained
Humankind has become increasingly reliant on satellites and space technology to conduct everyday life, be it GPS for navigation on the road or satellite in...
JAN 08, 2020
Chemistry & Physics
JAN 08, 2020
Florence Nightingale: Nursing Pioneer, and Data Scientist?
Florence Nightingale, the pioneer in modern nursing care, served as a nurse manager in the Crimean War in the 1850s. Due to her wholeheartedly devotion to...
JAN 23, 2020
Chemistry & Physics
JAN 23, 2020
Meet SF6, Our Frenemy in Fighting Climate Change
Sulfur hexafluoride, or SF6, is a non-flammable, non-toxic, synthetic gas. First discovered back in 1901, this odorless and colorless gas is commonly used...
JAN 27, 2020
Space & Astronomy
JAN 27, 2020
How Dangerous is Radiation on Mars?
One of humankind’s most ambitious goals for the next decade is preparing to send astronauts to Mars for the very first time. Such a feat is projected...
FEB 17, 2020
Space & Astronomy
FEB 17, 2020
SpaceX Launches More Starlink Satellites, But Fails First Stage Landing
SpaceX launched yet another one of its renowned Falcon 9 rockets on Monday, this time carrying a plethora of its Starlink satellites that will fortify the...
Loading Comments...